TY - JOUR
T1 - A framework for scabies control
AU - Engelman, Daniel
AU - Marks, Michael
AU - Steer, Andrew C.
AU - Beshah, Abate
AU - Biswas, Gautam
AU - Chosidow, Olivier
AU - Coffeng, Luc E.
AU - Lardizabal Dofitas, Belen
AU - Enbiale, Wendemagegn
AU - Fallah, Mosoka
AU - Gasimov, Elkhan
AU - Hopkins, Adrian
AU - Jacobson, Julie
AU - Kaldor, John M.
AU - Ly, Fatimata
AU - Mackenzie, Charles D.
AU - McVernon, Jodie
AU - Parnaby, Matthew
AU - Rainima-Qaniuci, Merelesita
AU - Sokana, Oliver
AU - Sankara, Dieudonne
AU - Yotsu, Rie
AU - Yajima, Aya
AU - Cantey, Paul T.
PY - 2021/9/1
Y1 - 2021/9/1
N2 - Scabies is a neglected tropical disease (NTD) that causes a significant health burden, particularly in disadvantaged communities and where there is overcrowding. There is emerging evidence that ivermectin-based mass drug administration (MDA) can reduce the prevalence of scabies in some settings, but evidence remains limited, and there are no formal guidelines to inform control efforts. An informal World Health Organization (WHO) consultation was organized to find agreement on strategies for global control. The consultation resulted in a framework for scabies control and recommendations for mapping of disease burden, delivery of interventions, and establishing monitoring and evaluation. Key operational research priorities were identified. This framework will allow countries to set control targets for scabies as part of national NTD strategic plans and develop control strategies using MDA for high-prevalence regions and outbreak situations. As further evidence and experience are collected and strategies are refined over time, formal guidelines can be developed. The control of scabies and the reduction of the health burden of scabies and associated conditions will be vital to achieving the targets set in WHO Roadmap for NTDs for 2021 to 2030 and the Sustainable Development Goals.
AB - Scabies is a neglected tropical disease (NTD) that causes a significant health burden, particularly in disadvantaged communities and where there is overcrowding. There is emerging evidence that ivermectin-based mass drug administration (MDA) can reduce the prevalence of scabies in some settings, but evidence remains limited, and there are no formal guidelines to inform control efforts. An informal World Health Organization (WHO) consultation was organized to find agreement on strategies for global control. The consultation resulted in a framework for scabies control and recommendations for mapping of disease burden, delivery of interventions, and establishing monitoring and evaluation. Key operational research priorities were identified. This framework will allow countries to set control targets for scabies as part of national NTD strategic plans and develop control strategies using MDA for high-prevalence regions and outbreak situations. As further evidence and experience are collected and strategies are refined over time, formal guidelines can be developed. The control of scabies and the reduction of the health burden of scabies and associated conditions will be vital to achieving the targets set in WHO Roadmap for NTDs for 2021 to 2030 and the Sustainable Development Goals.
UR - http://www.scopus.com/inward/record.url?scp=85115450787&partnerID=8YFLogxK
U2 - 10.1371/journal.pntd.0009661
DO - 10.1371/journal.pntd.0009661
M3 - Article
C2 - 34473725
AN - SCOPUS:85115450787
VL - 15
SP - e0009661
JO - PLoS Neglected Tropical Diseases
JF - PLoS Neglected Tropical Diseases
SN - 1935-2727
IS - 9
M1 - e0009661
ER -
